SF3B1 and myelodysplastic syndrome: Actually, SF3B1 mutations are detected in <7% of AdvSM patients (most frequently in SM-MDS cases [13,68,85]) (Table S3), while they are rarely found in Non-AdvSM patients [10,12,29,68] (Table 5).